NO20080162L - Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer - Google Patents

Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer

Info

Publication number
NO20080162L
NO20080162L NO20080162A NO20080162A NO20080162L NO 20080162 L NO20080162 L NO 20080162L NO 20080162 A NO20080162 A NO 20080162A NO 20080162 A NO20080162 A NO 20080162A NO 20080162 L NO20080162 L NO 20080162L
Authority
NO
Norway
Prior art keywords
compounds
flt3
tienopyrimidine
flt
kinase inhibitors
Prior art date
Application number
NO20080162A
Other languages
English (en)
Norwegian (no)
Inventor
Michael David Gaul
Kevin Douglas Kreutter
Christian Andrew Baumann
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20080162L publication Critical patent/NO20080162L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20080162A 2005-06-10 2008-01-09 Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer NO20080162L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68971005P 2005-06-10 2005-06-10
US74694106P 2006-05-10 2006-05-10
PCT/US2006/022151 WO2006135639A1 (en) 2005-06-10 2006-06-07 Thiξnopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors

Publications (1)

Publication Number Publication Date
NO20080162L true NO20080162L (no) 2008-03-07

Family

ID=37074647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080162A NO20080162L (no) 2005-06-10 2008-01-09 Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer

Country Status (19)

Country Link
US (3) US20060281768A1 (ru)
EP (1) EP1899355A1 (ru)
JP (1) JP2008543759A (ru)
KR (1) KR20080021126A (ru)
AR (1) AR057063A1 (ru)
AU (1) AU2006258049A1 (ru)
BR (1) BRPI0613644A2 (ru)
CA (1) CA2611587A1 (ru)
CR (1) CR9650A (ru)
EA (1) EA200800011A1 (ru)
EC (1) ECSP077992A (ru)
IL (1) IL187689A0 (ru)
MX (1) MX2007015741A (ru)
NI (1) NI200700311A (ru)
NO (1) NO20080162L (ru)
PE (1) PE20070070A1 (ru)
TW (1) TW200716651A (ru)
UY (1) UY29590A1 (ru)
WO (1) WO2006135639A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
DK3421471T3 (da) 2006-04-25 2021-06-14 Astex Therapeutics Ltd Purin- og deazapurinderivater som farmaceutiske forbindelser
JP2009534454A (ja) * 2006-04-25 2009-09-24 アステックス、セラピューティックス、リミテッド 医薬化合物
US20080076770A1 (en) * 2006-09-25 2008-03-27 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
KR101470933B1 (ko) 2007-09-14 2014-12-09 얀센 파마슈티카 엔.브이. 히스타민 ｈ4 수용체의 티에노- 및 푸로-피리미딘 조절제
MY150059A (en) 2007-10-11 2013-11-29 Astrazeneca Ab Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
EP2694056B1 (en) 2011-04-01 2019-10-16 AstraZeneca AB Therapeutic treatment
KR101960555B1 (ko) 2011-05-13 2019-03-20 어레이 바이오파마 인크. Trka 키나제 저해제로서의 피롤리디닐 유레아 및 피롤리디닐 티오유레아 화합물
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
WO2013079964A1 (en) 2011-11-30 2013-06-06 Astrazeneca Ab Combination treatment of cancer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
MA40434B1 (fr) 2014-05-15 2019-09-30 Array Biopharma Inc 1-((3s,4r)-4-(3-fluorophényl)-1-(2-méthoxyéthyl)pyrrolidin-3-yl)-3-(4-méthyl-3-(2-méthylpyrimidin-5-yl)-1-phényl-1h-pyrazol-5-yl)urée comme inhibiteur de la kinase trka
EP3559006A4 (en) * 2016-12-23 2021-03-03 Arvinas Operations, Inc. COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FETAL LIVER KINASE POLYPEPTIDES
TW202039481A (zh) 2018-12-21 2020-11-01 美商西建公司 Ripk2之噻吩并吡啶抑制劑

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239506T1 (de) * 1992-03-05 2003-05-15 Univ Texas Verwendung von immunokonjugate zur diagnose und/oder therapie der vaskularisierten tumoren
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
US5932765A (en) * 1997-05-23 1999-08-03 Merck Patent Gesellschaft Mit Nitromethyl ketones, process for preparing them and compositions containing them
CN101328186A (zh) * 1997-11-11 2008-12-24 辉瑞产品公司 用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物
CN1291892A (zh) * 1998-01-27 2001-04-18 阿温蒂斯药物制品公司 取代的氧代氮杂杂环基因子Xa抑制剂
CA2372053C (en) * 1999-04-28 2008-09-02 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting vegf
US6776796B2 (en) * 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
TWI238824B (en) * 2001-05-14 2005-09-01 Novartis Ag 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives
US7105505B2 (en) * 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
CA2495383A1 (en) * 2002-08-12 2004-02-26 Takeda Pharmaceutical Company Limited Fused benzene derivative and use
AU2003280599A1 (en) * 2002-10-29 2004-05-25 Kirin Beer Kabushiki Kaisha QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US20060281769A1 (en) * 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators

Also Published As

Publication number Publication date
KR20080021126A (ko) 2008-03-06
EP1899355A1 (en) 2008-03-19
JP2008543759A (ja) 2008-12-04
AU2006258049A8 (en) 2006-12-21
IL187689A0 (en) 2008-08-07
AR057063A1 (es) 2007-11-14
MX2007015741A (es) 2008-04-29
WO2006135639A1 (en) 2006-12-21
EA200800011A1 (ru) 2008-06-30
NI200700311A (es) 2009-03-03
US20090143378A1 (en) 2009-06-04
TW200716651A (en) 2007-05-01
US20090163710A1 (en) 2009-06-25
BRPI0613644A2 (pt) 2011-01-25
UY29590A1 (es) 2006-10-02
CA2611587A1 (en) 2006-12-21
US20060281768A1 (en) 2006-12-14
CR9650A (es) 2008-09-09
ECSP077992A (es) 2008-01-23
PE20070070A1 (es) 2007-03-08
AU2006258049A1 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
NO20080162L (no) Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer
NO20080168L (no) Aminoquinolin- og aminoquinoazolinkinasemodulatorer
NO20083013L (no) Triazolopyridaziner som tyrosinkinasemodulatorer
NO20080174L (no) Alkylquinolin- og alkylquinazolinkinasemodulatorer
NO20080163L (no) Aminopyrimidiner som kinasemodulatorer
NO20080161L (no) Aminopyrimidiner som kinasemodulatorer
NO20061194L (no) Mitotiske kinesininbibitorer
EA200870373A1 (ru) Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
WO2008035209A3 (en) Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity
EA201101583A1 (ru) Ингибиторы pi3 киназы или mtor
EA201000366A1 (ru) Производные 2-бифениламино-4-аминопиримидина в качестве ингибиторов киназ
NO20076659L (no) Pyrrolo(2,3-B)pyridinderivater som protein kinase inhibitorer
NO20070506L (no) Fremgangsmater og mellomprodukter nyttige for fremstilling av kondenserte heterocykliske kinase inhibitorer.
MY156536A (en) Inhibitors of protein tyrosine kinase activity
MX2009003650A (es) Nuevos imidazotiazoles e imidazoxazoles.
NO20090608L (no) Tyrosinkinaseinhibitorer
NO20080417L (no) Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET
MX2010007927A (es) Derivados de 4-(pirrolo[2,3-c]piridin-3-il)pirimidin-2-ilamina.
EA200800374A1 (ru) 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции
EA201001576A1 (ru) Тиенопиримидины
NZ630353A (en) Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
UA109764C2 (uk) Похідні ізохінолінону, композиція на їх основі та застосування як інгібіторів рі3k

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application